1. Home
  2. TMDX vs ICHR Comparison

TMDX vs ICHR Comparison

Compare TMDX & ICHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$86.30

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo Ichor Holdings

ICHR

Ichor Holdings

HOLD

Current Price

$54.82

Market Cap

3.0B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
TMDX
ICHR
Founded
1998
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
3.0B
IPO Year
2019
2016

Fundamental Metrics

Financial Performance
Metric
TMDX
ICHR
Price
$86.30
$54.82
Analyst Decision
Buy
Strong Buy
Analyst Count
9
6
Target Price
$148.22
$49.50
AVG Volume (30 Days)
623.7K
559.1K
Earning Date
05-05-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
382.18
N/A
EPS
0.61
N/A
Revenue
$605,494,000.00
$947,652,000.00
Revenue This Year
$24.25
$20.51
Revenue Next Year
$18.75
$17.08
P/E Ratio
$142.07
N/A
Revenue Growth
37.13
11.61
52 Week Low
$60.11
$14.06
52 Week High
$156.00
$113.58

Technical Indicators

Market Signals
Indicator
TMDX
ICHR
Relative Strength Index (RSI) 51.89 41.54
Support Level $80.29 $49.80
Resistance Level $95.18 $59.00
Average True Range (ATR) 4.40 2.31
MACD -0.41 0.60
Stochastic Oscillator 70.10 45.22

Price Performance

Historical Comparison
TMDX
ICHR

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About ICHR Ichor Holdings

Ichor Holdings Ltd designs, engineers, and manufactures critical fluid delivery subsystems and components mainly for semiconductor capital equipment, along with solutions for defense/aerospace and medical industries. Its product portfolio includes gas and chemical delivery subsystems that enable precise delivery, monitoring, and control of specialized gases and reactive liquid chemistries used in semiconductor manufacturing processes such as etch, electroplating, and cleaning. The company also provides precision-machined components, weldments, e-beam and laser-welded components, as well as precision vacuum and hydrogen brazing. Geographically, the company operates across the United States, Singapore, Europe, and other regions, with Singapore contributing the majority of revenue.

Share on Social Networks: